These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10084418)

  • 41. Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group.
    Plouffe J; Schwartz DB; Kolokathis A; Sherman BW; Arnow PM; Gezon JA; Suh B; Anzuetto A; Greenberg RN; Niederman M; Paladino JA; Ramirez JA; Inverso J; Knirsch CA
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1796-802. PubMed ID: 10858333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telithromycin: the first of the ketolides.
    Shain CS; Amsden GW
    Ann Pharmacother; 2002 Mar; 36(3):452-64. PubMed ID: 11895060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects.
    Wilms EB; Touw DJ; Heijerman HG; van der Ent CK
    Pediatr Pulmonol; 2012 Jul; 47(7):658-65. PubMed ID: 22684985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
    Bogdanov MB; Chernen'kaia TV
    Antibiot Khimioter; 2000; 45(10):15-8. PubMed ID: 11212394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic.
    Veve MP; Wagner JL
    Pharmacotherapy; 2018 Sep; 38(9):935-946. PubMed ID: 30019769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function.
    Canut A; Isla A; Rodríguez-Gascón A
    Int J Antimicrob Agents; 2015 Apr; 45(4):399-405. PubMed ID: 25700566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azithromycin extended release: a review of its use in the treatment of acute bacterial sinusitis and community-acquired pneumonia in the US.
    Swainston Harrison T; Keam SJ
    Drugs; 2007; 67(5):773-92. PubMed ID: 17385947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
    Girard D; Finegan SM; Dunne MW; Lame ME
    J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.
    Treyaprasert W; Schmidt S; Rand KH; Suvanakoot U; Derendorf H
    Int J Antimicrob Agents; 2007 Mar; 29(3):263-70. PubMed ID: 17194570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levofloxacin in the treatment of community-acquired pneumonia.
    Noreddin AM; Elkhatib WF
    Expert Rev Anti Infect Ther; 2010 May; 8(5):505-14. PubMed ID: 20455679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Characteristics and clinical efficacy of the sustained-release formulation of azalide azithromycin].
    Kohno S
    Jpn J Antibiot; 2009 Aug; 62(4):269-76. PubMed ID: 19860319
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease.
    Bevan CD; Ridgway GL; Rothermel CD
    J Int Med Res; 2003; 31(1):45-54. PubMed ID: 12635534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
    Segreti J; House HR; Siegel RE
    Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetic and clinical evaluation of azithromycin using fine granules or capsules in the pediatric patients].
    Toyonaga Y; Ishihara T; Nakamura H
    Jpn J Antibiot; 1996 Nov; 49(11):981-93. PubMed ID: 8988410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lefamulin (Xenleta) for community-acquired bacterial pneumonia.
    Med Lett Drugs Ther; 2019 Sep; 61(1581):145-148. PubMed ID: 31599865
    [No Abstract]   [Full Text] [Related]  

  • 57. 13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.
    Roig J; Casal J; Gispert P; Gea E
    Med Mal Infect; 2006; 36(11-12):680-9. PubMed ID: 17095177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections.
    Van Wart S; Phillips L; Ludwig EA; Russo R; Gajjar DA; Bello A; Ambrose PG; Costanzo C; Grasela TH; Echols R; Grasela DM
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4766-77. PubMed ID: 15561855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila.
    Tan JS; File TM; DiPersio JR; DiPersio LP; Hamor R; Saravolatz LD; Stout JE
    Clin Infect Dis; 2001 Jun; 32(11):1562-6. PubMed ID: 11340527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.